18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Last updated
Summary
Product
18F-Fludeoxyglucose (18F-FDG)
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Isologic Innovative Radiopharmaceuticals |
18F-FLUDEOXYGLUCOSE (18F-FDG) |
DIN 02328739 |
Solution |
Fludeoxyglucose 18F 7400 MBq / mL |
L06DEC22-4 |
Issue
Product sterility may be compromised in the affected lot.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Healthcare Establishments
Details
Original published date: 2022-12-14
Alert / recall type
Health product recall
Category
Health product - Drugs - Radiopharmaceuticals
Companies
Isologic Innovative Radiopharmaceuticals Inc.
1855 32e Avenue,
Lachine, QC, H8T 3J1, Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-72366